Alpha DNA Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,832	Closed	-$562K	–	242
2023 Q4	$562K	Buy	+5,832	New	+$562K	0.22%	89
2022 Q1	–	Sell	-17,522	Closed	-$1.58M	–	150
2021 Q4	$1.58M	Buy	+17,522	New	+$1.58M	1%	45